Orchid Pharma Ltd

NSE :ORCHPHARMA   BSE :524372  Sector : Pharmaceuticals
Buy, Sell or Hold ORCHPHARMA? Ask The Analyst

BSE


prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE


prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

18 May
1075.10
(-1.68%)
17 May
1093.45
(1.20%)
16 May
1080.50
(-1.66%)
15 May
1098.70
(8.28%)
14 May
1014.65
(-0.02%)
13 May
1014.85
(-1.91%)
10 May
1034.65
(1.46%)
09 May
1019.75
(-1.23%)
08 May
1032.45
(3.70%)
07 May
995.65
(-2.37%)
06 May
1019.85
(-2.32%)
03 May
1044.10
(-1.46%)
02 May
1059.55
(-1.77%)
30 Apr
1078.65
(-0.86%)
29 Apr
1088.00
(0.34%)
26 Apr
1084.35
(-0.74%)
25 Apr
1092.40
(2.57%)
24 Apr
1065.00
(0.84%)
23 Apr
1056.10
(0.25%)
22 Apr
1053.50
(-1.06%)
19 Apr
1064.80
(-0.60%)


Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Neutral

Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bullish

1071.25


10 DMA
Bullish

1044.71


20 DMA
Bullish

1054.27


50 DMA
Bullish

1065.9


100 DMA
Bullish

977.65


200 DMA
Bullish

763.83



Intraday Support and Resistance
(Based on Pivot Points) |

Updated On May 18, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1123.8 1111.4 1083.5 - -
R2 1111.4 1099.73 1080.7 1109.96 -
R1 1093.25 1092.52 1077.9 1090.37 1102.33
P 1080.85 1080.85 1080.85 1079.41 1085.39
S1 1062.7 1069.18 1072.3 1059.82 1071.78
S2 1050.3 1061.97 1069.5 1048.86 -
S3 1032.15 1050.3 1066.7 - -

Key Metrics

EPS

17.41

P/E

61.67

P/B

4.72

Dividend Yield

0%

Market Cap

5,453 Cr.

Face Value

10

Book Value

227.45

ROE

0.29%

EBITDA Growth

42.01 Cr.

Debt/Equity

0.45

Shareholding Pattern

  69.84% Total Promoter Holding
15.18% Mutual Fund Holdings
1.96% FIIs
10.47% Non Institution
0.94% Insurance Companies
0% Custodians
1.61% Other Parties

Shareholding History


Quarterly Result (Figures in Rs. Crores)


Orchid Pharma Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 168.69 250.84 184.81 207.11 228.21
PROFIT 7.59 26.7 9.4 19.8 29.43
EPS 1.86 14.49 1.85 4.3 6.18

Orchid Pharma Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 168.69 250.84 184.81 206.94 228.03
PROFIT 6.73 26.72 10.78 20.24 30.55
EPS 1.65 15.89 2.64 4.4 6.42

Profit & Loss (Figures in Rs. Crores)


Orchid Pharma Ltd Profit & Loss


Sep 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 2010.88 1893.37 904.92 804.22 695.72 791.28 526.41 482.36 654.09 746.02
PROFIT -609.27 -310.04 -226.56 -409.18 -352.81 -131.52 -131.16 -118.41 -2.46 6.32
EPS 0 0 0 0 0 7.8 0 -28.55 0.39 11.88

Orchid Pharma Ltd Profit & Loss


Sep 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 1968.82 1882.85 888.65 780.78 661.47 781.08 525.56 472.85 636.67 746.02
PROFIT -571.56 -304.43 -221.72 -402.29 -355.32 -125.99 -149.93 -118.13 -5.32 14.19
EPS 0 0 0 0 0 -11.36 -36.71 -28.7 -1.18 13.28

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2013
SOURCES OF FUNDS :
Share Capital 40.8240.8240.8240.8288.9688.9688.9688.9685.2670.45
Reserves Total 579.27538543.53725.17-793-880.72-555.71-39.92244.12309.53
Equity Application Money68.5668.5668.560000000
Total Shareholders Funds688.65647.38652.91765.99-704.04-791.76-466.7549.04329.38379.98
Minority Interest0000000000.62
Secured Loans 264.15207.58389.24491.923,091.653,064.843,104.832,872.292,984.882,336.69
Unsecured Loans 67.1960.3863.574.47138.31137.111.33342.3225.78867.46
Total Debt331.34267.96452.74566.393,229.963,201.953,106.163,214.593,210.663,204.15
Other Liabilities12.611.0111.5411.797.77.485.923.734.185.24
Total Liabilities1,032.59926.351,117.191,344.172,533.622,417.672,645.333,267.363,544.223,589.99
APPLICATION OF FUNDS :
Gross Block 1,220.561,176.391,176.11,247.111,519.481,519.491,636.893,005.873,002.153,772.17
Less: Accumulated Depreciation647.47592.68505.66389.18263.22133.28140.341,369.041,206.951,188.6
Net Block573.09583.71670.44857.931,256.261,386.211,496.551,636.831,795.22,583.57
Capital Work in Progress46.469.787.4325.61278.16271.53288.31280.4281.51360.42
Investments 44.4445.4915.430.340.471.071.140.810.810.95
Inventories 228.74172.66152.89141.69169.77193.74211.25241.85251.93506.24
Sundry Debtors 215.19170.57135.767.97119.89119.51164.65310.07256.57179.06
Cash and Bank Balance30.638.0619.91174.04325.52305.55257.06314.94390.5723.42
Loans and Advances 26.4546.37226.34185.62152.2760.1442.16384.33379.06392.7
Total Current Assets501.01397.65534.84569.32767.46678.95675.121,251.21,278.121,101.42
Current Liabilities 185.9177.98113.31109.27536.56703.44559.51456.35353.73872.5
Provisions 3.493.013.523.253.631.031.3344.2252.2331.17
Total Current Liabilities & Provisions189.39180.99116.84112.52540.2704.47560.84500.57405.96903.67
Net Current Assets311.62216.66418456.8227.26-25.52114.29750.63872.16197.75
Deferred Tax Assets86.1182.83149.34197.5240.3294.1400055.1
Deferred Tax Liability89.3386.06152.57200.72243.5497.3749.4294.14111.21212.47
Net Deferred Tax-3.22-3.23-3.23-3.22-3.22-3.23-49.42-94.14-111.21-157.37
Other Assets60.273.949.116.7774.68787.62794.47692.83705.75604.68
Total Assets1,032.6926.351,117.191,344.172,533.612,417.672,645.333,267.363,544.233,590
Contingent Liabilities41.9542.8845.120142.9161.53181.2171.32107.03168.28
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Sep 2013
SOURCES OF FUNDS :
Share Capital 40.8240.8240.8240.8288.9688.9688.9688.9685.2670.45
Reserves Total 622.59568.58571.96688.45-843.95-763.1-431.8882.17354.14417.71
Equity Application Money68.5668.5668.5668.56000000
Total Shareholders Funds731.97677.96681.34797.83-754.99-674.14-342.92171.13439.4488.16
Secured Loans 222.59170.63366.84491.923,091.653,064.843,104.833,075.553,054.942,336.68
Unsecured Loans 108.7597.3285.974.47138.31137.111.33138.87155.72867.46
Total Debt331.34267.95452.74566.393,229.963,201.953,106.163,214.423,210.663,204.14
Other Liabilities12.611.0111.5411.797.77.485.923.734.185.24
Total Liabilities1,075.91956.921,145.621,376.012,482.672,535.292,769.163,389.283,654.243,697.54
APPLICATION OF FUNDS :
Gross Block 1,220.451,176.261,175.971,246.981,424.571,424.571,540.432,893.192,889.73,659.71
Less : Accumulated Depreciation 647.39592.6505.58389.12263.22133.29138.721,352.831,192.61,176.9
Net Block 573.06583.66670.39857.861,161.351,291.281,401.711,540.361,697.12,482.81
Capital Work in Progress46.099.787.4325.61278.16271.53288.31280.4281.51360.42
Investments 50.1249.0115.430.340.47124.77124.84124.65124.65124.18
Inventories 228.74172.66150.57140.78167.11184.94197.45210.34242.28500.08
Sundry Debtors 211.91160.23131.9666.38140.73145.07208.07375.44290.16183.7
Cash and Bank Balance22.344.2118.97172.32324.17301.04256.04313.11389.5722.4
Loans and Advances 30.8145.99225.73185.29151.4559.7541.5425.23424.78445.52
Total Current Assets493.79383.08527.23564.77783.46690.8703.061,324.121,346.791,151.69
Current Liabilities 140.64131.0472.167.51503.73671.21538.43434.88338.17836.61
Provisions 3.493.013.523.253.631.031.3344.2252.2331.17
Total Current Liabilities & Provisions144.12134.0575.6270.76507.37672.24539.76479.1390.4867.78
Net Current Assets349.67249.03451.61494.01276.0918.56163.3845.02956.39283.91
Deferred Tax Assets86.1182.83149.34197.5240.32000054.58
Deferred Tax Liability89.3386.06152.57200.72243.543.2349.4294.14111.39212.47
Net Deferred Tax-3.22-3.23-3.23-3.22-3.22-3.23-49.42-94.14-111.39-157.89
Other Assets60.268.6741.41769.81832.39840.43692.99705.97604.12
Total Assets1,075.92956.921,145.631,376.012,482.662,535.32,769.163,389.283,654.233,697.55
Contingent Liabilities38.1642.8845.120142.9161.53181.2171.32107.03187.06

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...46.32
Depreciation54.79
Interest (Net)31.61
P/L on Sales of Assets-39.99
P/L on Sales of Invest-0.02
Prov. and W/O (Net)1.19
P/L in Forex1.64
Total Adjustments (PBT and Ext...51.38
Operating Profit before Workin...97.7
Trade and 0ther Receivables-41.65
Inventories-56.08
Trade Payables13.91
Total Adjustments (OP before W...-79.06
Cash Generated from/(used in) ...18.64
Direct Taxes Paid-0.3
Total Adjustments(Cash Generat...-0.3
Cash Flow before Extraordinary...18.34
Net Cash from Operating Activi...18.34
Purchased of Fixed Assets-84.91
Sale of Fixed Assets58.55
Purchase of Investments-1.03
Interest Received0.46
Net Cash used in Investing Act...-31.21
Proceed from 0ther Long Term B...173.2
Of the Long Tem Borrowings-109.81
Interest Paid-32.23
Net Cash used in Financing Act...31.17
Net Profit before Tax and Extr...54.19
Depreciation54.79
Interest (Net)31.61
P/L on Sales of Assets-39.99
P/L on Sales of Invest-0.02
Prov. and W/O (Net)1.19
P/L in Forex6.51
Total Adjustments (PBT and Ext...54.1
Operating Profit before Workin...108.29
Trade and 0ther Receivables-48.7
Inventories-56.08
Trade Payables15.6
Total Adjustments (OP before W...-94.6
Cash Generated from/(used in) ...13.69
Direct Taxes Paid-0.3
Total Adjustments(Cash Generat...-0.3
Cash Flow before Extraordinary...13.39
Net Cash from Operating Activi...13.39
Purchased of Fixed Assets-84.55
Sale of Fixed Assets58.55
Purchase of Investments-1.04
Interest Received0.62
Net Cash used in Investing Act...-26.7
Proceed from Short Tem Borrowi...173.2
Of the Long Tem Borrowings-109.81
Interest Paid-32.23
Net Cash used in Financing Act...31.17

Company Details

Registered Office
AddressOrchid Towers Nungambakkam,
313 Valluvar Kottam High Road
CityChennai
StateTamil Nadu
Pin Code600034
Tel. No.91-44-28211000/28230000
Fax. No.91-44-28211002
Emailcorporate@orchidpharma.com
Internethttp://www.orchidpharma.com
Registrars
AddressOrchid Towers Nungambakkam
CityChennai
StateTamil Nadu
Pin Code600034
Tel. No.91-44-28211000/28230000
Fax. No.91-44-28211002
Emailcorporate@orchidpharma.com
Internethttp://www.orchidpharma.com
Management
Name Designation
Tanu SinglaIndependent Director
Dharam VirIndependent Director
Mudit TandonIndependent Director
Manoj GoyalIndependent Director
Manish DhanukaManaging Director
Mridul DhanukaWhole-time Director
Ram Gopal AgarwalChairman (Non-Executive)